TARDBP and frontotemporal dementia: Although how TDP-43 forms cytoplasmic aggregates and causes neurodegeneration in patients with ALS/FTD remains unclear, a reduction in cellular TDP-43 levels will likely prevent its aggregation and potentially rescue neurons from TDP-43 toxicity.